Mar 10, 2023 5:17pm EST Virax Biolabs Group Limited Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Mar 08, 2023 8:55am EST Virax Biolabs Group Limited Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
Mar 07, 2023 7:30am EST Virax Biolabs Group Limited Introduces Avian Influenza A Virus Real-Time PCR Test Kit
Feb 07, 2023 8:30am EST Virax Biolabs Group Limited Announces Purchase Order to Launch COVID-19 and Influenza A+B Antigen Combo Rapid Tests with Cosmos Health (NASDAQ:COSM)
Dec 06, 2022 7:30am EST COVID-19 Rapid Antigen Test Distributed By Virax Biolabs Receives Emergency Use Authorization in the United States
Nov 15, 2022 7:30am EST Virax Biolabs Appoints Richard Pallin as the Vice President of In Vitro Diagnostic Sales
Nov 08, 2022 4:30pm EST Virax Biolabs Group Limited Announces Closing of $3.8 Million Private Placement
